These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31991892)

  • 1. The 25(OH)Vitamin D Status Affected the Effectiveness of Oligo Fucoidan in Patients with Chronic Hepatitis B Virus Infection with Immune Tolerance Phase.
    Ko WS; Shen FP; Shih CJ; Chiou YL
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 31991892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Study of Correlation Between Serum Vitamin D
    Ko WS; Yang YP; Shen FP; Wu MC; Shih CJ; Lu MC; Yan YH; Chiou YL
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of Vitamin D in immune response in patients with viral hepatitis.
    Gerhards C; Teufel A; Gerigk M; French M; Antoni C; Ebert M; Neumaier M; Evliyaoglu O
    Nutrition; 2024 Aug; 124():112447. PubMed ID: 38669827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients.
    Farnik H; Bojunga J; Berger A; Allwinn R; Waidmann O; Kronenberger B; Keppler OT; Zeuzem S; Sarrazin C; Lange CM
    Hepatology; 2013 Oct; 58(4):1270-6. PubMed ID: 23703797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Serum Vitamin D Levels on Cellular Immunity and Antiviral Effects in Chronic Hepatitis B Patients.
    He LJ; Zhang HP; Li HJ; Wang J; Chang DD
    Clin Lab; 2016 Oct; 62(10):1933-1939. PubMed ID: 28164523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients.
    You J; Sriplung H; Geater A; Chongsuvivatwong V; Zhuang L; Li YL; Lei H; Liu J; Chen HY; Tang BZ; Huang JH
    BMC Infect Dis; 2008 Sep; 8():123. PubMed ID: 18803883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review.
    Hoan NX; Tong HV; Song LH; Meyer CG; Velavan TP
    World J Gastroenterol; 2018 Jan; 24(4):445-460. PubMed ID: 29398866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss.
    Zheng Q; Zhu YY; Chen J; Liu YR; You J; Dong J; Zeng DW; Gao LY; Chen LH; Jiang JJ
    J Viral Hepat; 2014 Dec; 21(12):909-16. PubMed ID: 24888640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
    Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the changes in immune cells and HBeAg loss following antiviral treatment in chronic hepatitis B patients].
    Zheng Q; Zhu YY; Chen J; Liu YR; You J; Zeng DW; Lin S; Jiang JJ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):801-6. PubMed ID: 23206296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of T-cell FoxP3⁺ Treg and CD4⁺/CD8⁺ PD-1 expression is related to HBeAg seroconversion in hepatitis B patients on pegylated interferon.
    Ma H; Zhang HH; Wei L
    Chin Med J (Engl); 2013 Jan; 126(2):267-73. PubMed ID: 23324275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
    Evans A; Riva A; Cooksley H; Phillips S; Puranik S; Nathwani A; Brett S; Chokshi S; Naoumov NV
    Hepatology; 2008 Sep; 48(3):759-69. PubMed ID: 18697210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
    Dusséaux M; Masse-Ranson G; Darche S; Ahodantin J; Li Y; Fiquet O; Beaumont E; Moreau P; Rivière L; Neuveut C; Soussan P; Roingeard P; Kremsdorf D; Di Santo JP; Strick-Marchand H
    Gastroenterology; 2017 Dec; 153(6):1647-1661.e9. PubMed ID: 28851562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
    Rinker F; Zimmer CL; Höner Zu Siederdissen C; Manns MP; Kraft ARM; Wedemeyer H; Björkström NK; Cornberg M
    J Hepatol; 2018 Sep; 69(3):584-593. PubMed ID: 29758333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load.
    You J; Zhuang L; Zhang YF; Chen HY; Sriplung H; Geater A; Chongsuvivatwong V; Piratvisuth T; McNeil E; Yu L; Tang BZ; Huang JH
    World J Gastroenterol; 2009 Jul; 15(27):3382-93. PubMed ID: 19610139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establish a predictive modeling under antiviral therapy for hepatitis B e antigen seroconversion in chronic hepatitis B].
    Liu GW; Tang KC; Li Q; Lu W
    Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):641-645. PubMed ID: 30481858
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
    Huang H; Wang J; Li W; Chen R; Chen X; Zhang F; Xu D; Lu F
    J Clin Virol; 2018; 99-100():71-78. PubMed ID: 29353073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.
    Lau GK; Nanji A; Hou J; Fong DY; Au WS; Yuen ST; Lin M; Kung HF; Lam SK
    J Viral Hepat; 2002 Jul; 9(4):280-7. PubMed ID: 12081605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
    Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
    Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.